黄芩苷对溃疡性结肠炎CD4~+CD29~+抑制作用随机平行对照研究 |
| |
引用本文: | 于丰彦,;黄绍刚,;张海燕,;迟宏罡,;郑学宝.黄芩苷对溃疡性结肠炎CD4~+CD29~+抑制作用随机平行对照研究[J].实用中医内科杂志,2014(12):113-115. |
| |
作者姓名: | 于丰彦 ;黄绍刚 ;张海燕 ;迟宏罡 ;郑学宝 |
| |
作者单位: | [1]广东医学院中医研究室,广州524023; [2]广东省中医院大学城分院脾胃科,广州511495 |
| |
基金项目: | 国家自然科学基金(NO:30772701);东莞市科技计划项目(NO:2008108101032) |
| |
摘 要: | 目的]观测黄芩苷对溃疡性结肠炎患者CD4+CD29+抑制作用。方法]使用随机平行对照方法,按抛硬币方法简单随机分溃疡性结肠炎组33例,IBS-D组30例,健康对照组30例。流式细胞仪检测UC患者CD4+CD29+的表达及MTS法检测细胞增殖。结果]UC患者外周血中CD4+CD29+T细胞发现与健康对照组和IBS-D组相比,CD4+和CD4+CD29+增高;黄芩苷干预,第2和3天抑制增殖明显,在40umol和20umol浓度干预下CD4+CD29+较未干预前、DMSO干预、5umol干预和10umol干预之间有明显差异。结论]黄芩苷能通过抑制CD4+CD29+增殖作用治疗溃疡性结肠炎。
|
关 键 词: | 溃疡性结肠炎 腹泻型肠易激综合征 CD4+CD29+T细胞 黄芩苷 CD4/29抗体 细胞增殖 随机平行对照研究 |
Baicalin on Ulcerative Colitis CD4~+CD29~+ Inhibition Randomized Parallel Group Study |
| |
Institution: | YU Fengyan,HUANG Shaogang,ZHANG Haiyan,CHI Honggang,ZHENG Xue Bao(1.Guangdong Chinese Medicine Laboratory Medicine, Guangzhou 524023,China; 2.Guangdong Provincial Hospital of the University City Branch Spleen and stomach department Branch, Guangzhou 511495,China) |
| |
Abstract: | Objective]Baicalin on patients with ulcerative colitis CD4+CD+29 inhibition. Methods] UC patients by flow cytometry CD4+CD29+ expression and cell proliferation MTS assay. Results]UC peripheral blood of patients with CD4+CD29+T cells found that compared with healthy controls and IBS-D group, CD4 +and CD4+CD+29increased; under baicalin intervention, 2 and 3 days inhibited proliferation evident in 40 umol and 20 umol concentration of CD4+CD29+intervention than before not intervene, there is a significant difference between DMSO intervention, 5umol intervention and 10 umol intervention.Conclusion]Baicalin as an important component of HQT one may treat ulcerative colitis by inhibiting the proliferation of CD4+CD29+. |
| |
Keywords: | Ulcerative colitis Diarrhea-predominant irritable bowel syndrome CD4+CD29+T cells Baicalin 9CD4 / 29 antibody Cell proliferation Randomized parallel group study |
本文献已被 CNKI 维普 等数据库收录! |
|